| Ytd | 49.54% | |
| 1y | 118.51% |
| Open | 244.65 | Prev Close | 243.47 | Low | 242.11 | High | 255.20 | Mkt Cap | 15.97B |
| Vol | 810.12K | Avg Vol | 890.85K | EPS | 12.86 | P/E | 19.77 | Forward P/E | 12.95 |
| Beta | 0.32 | Short Ratio | 3.71 | Inst. Own | 107.97% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-04 | 50-d Avg | 235.42 | 200-d Avg | 186.66 | 1yr Est | 260.26 |
Jazz (JAZZ) has an impressive earnings surprise history and currently possesses the right combinatio
DUBLIN, July 20, 2026 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced it wil
Wall Street analysts change ratings for FITB, TRVI, JAZZ, GPN, EAT, URBN, MNST. See full list on ben
Wall Street analysts change outlook on top stocks. For detailed ratings, upgrades/downgrades, see an
Canaccord Genuity analyst Gary Nachman initiates coverage on Jazz Pharmaceuticals (NASDAQ:JAZZ) w
Summary: Wall Street analysts changed rating for JAZZ, AFRM, MNDY, NGEN, FCEL, RRR, ABNB, KARO. See
Wells Fargo analyst Mohit Bansal maintains Jazz Pharmaceuticals (NASDAQ:JAZZ) with a Overweight a
Barclays analyst Etzer Darout maintains Jazz Pharmaceuticals (NASDAQ:JAZZ) with a Overweight and
Deutsche Bank analyst Gregg Gilbert maintains Jazz Pharmaceuticals (NASDAQ:JAZZ) with a Buy and r
Truist Securities analyst Gregory Renza maintains Jazz Pharmaceuticals (NASDAQ:JAZZ) with a Buy a
Jazz Pharmaceuticals teams with AbCellera on cancer therapies as analysts maintain positive targets
The collaboration includes $56 million in upfront payments to AbCellera and up to $792 million in po
Wall Street analysts change outlook on top names, including upgrades/downgrades. Check our analyst r
Top analysts changed outlook on top names. Check analyst ratings page for upgrades, downgrades, init
Companies Reporting Before The Bell • ICL Group (NYSE:ICL) is likely to report quarterly earnings a
Companies Reporting Before The Bell • Fresh Del Monte Produce (NYSE:FDP) is likely to report qua
Before 10 a.m. ET on Tuesday, 125 stocks hit new 52-week highs.